Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SH) has announced that shareholder Huang Ganyi intends to reduce his holdings by up to 15.3923 million shares, representing no more than 2.46% of the company's total share capital, according to a recent disclosure.

The reduction plan will be executed within 90 days following the completion of the mandatory 15-trading-day pre-disclosure period, spanning from October 19, 2026, to January 16, 2027. This passive reduction, as outlined in the notice of planned share disposal submitted by Huang Ganyi, is subject to regulatory requirements.

The company confirmed receiving the formal notification regarding this passive reduction initiative, which aligns with the shareholder's compliance obligations under relevant securities regulations.